Publikationen von Stefan H. E. Kaufmann
Alle Typen
Zeitschriftenartikel (695)
2012
Zeitschriftenartikel
56 (4), S. 1735 - 1743 (2012)
Antigen 85C Inhibition Restricts Mycobacterium tuberculosis Growth through Disruption of Cord Factor Biosynthesis. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Zeitschriftenartikel
80 (3), S. 1274 - 1279 (2012)
Experimental Cerebral Malaria Develops Independently of Caspase Recruitment Domain-Containing Protein 9 Signaling. Infection and Immunity
Zeitschriftenartikel
80 (3), S. 1274 - 1279 (2012)
Experimental Cerebral Malaria Develops Independently of Caspase Recruitment Domain-Containing Protein 9 Signaling. Infection and Immunity
Zeitschriftenartikel
5 (2), S. 129 - 139 (2012)
Genetic and pharmacological targeting of TPL-2 kinase ameliorates experimental colitis: a potential target for the treatment of Crohn's disease. Mucosal Immunology
Zeitschriftenartikel
92 (2), S. 182 - 186 (2012)
Ability of Cricetomys rats to detect Mycobacterium tuberculosis and discriminate it from other microorganisms. Tuberculosis
Zeitschriftenartikel
92 (Suppl. 1), S. S17 - S20 (2012)
Ten challenges for TB biomarkers. TUBERCULOSIS
Zeitschriftenartikel
8, S. 290 - 299 (2012)
The volatiles of pathogenic and nonpathogenic mycobacteria and related bacteria. Beilstein Journal of Organic Chemistry
Zeitschriftenartikel
42 (2), S. 374 - 384 (2012)
Activation of the NLRP3 inflammasome by Mycobacterium tuberculosis is uncoupled from susceptibility to active tuberculosis. European Journal of Immunology
Zeitschriftenartikel
50 (2), S. 274 - 280 (2012)
Diagnosis of Tuberculosis by Trained African Giant Pouched Rats and Confounding Impact of Pathogens and Microflora of the Respiratory Tract. Journal of Clinical Microbiology
Zeitschriftenartikel
15 (1), S. 63 - 70 (2012)
Floating between the poles of pathology and protection: can we pin down the granuloma in tuberculosis? CURRENT OPINION IN MICROBIOLOGY
Zeitschriftenartikel
12, 10 (2012)
Potential of novel Mycobacterium tuberculosis infection phase-dependent antigens in the diagnosis of TB disease in a high burden setting. BMC Infectious Diseases
Zeitschriftenartikel
13 (1), S. 71 - 82 (2012)
Identification of biomarkers for tuberculosis disease using a novel dual-color RT-MLPA assay. Genes and Immunity 2011
Zeitschriftenartikel
204 (10), S. 1573 - 1584 (2011)
Recombinant BCG Delta ureC hly plus Induces Superior Protection Over Parental BCG by Stimulating a Balanced Combination of Type 1 and Type 17 Cytokine Responses. Journal of Infectious Diseases
Zeitschriftenartikel
29 (47), S. 8740 - 8744 (2011)
Improved long-term protection against Mycobacterium tuberculosis Beijing/W in mice after intra-dermal inoculation of recombinant BCG expressing latency associated antigens. Vaccine
Zeitschriftenartikel
17 (9), S. 1323 - 1331 (2011)
Suppressor of cytokine signaling-3 is affected in T-cells from tuberculosisTB patients. Clinical Microbiology and Infection
Zeitschriftenartikel
11 (8), S. 633 - 640 (2011)
Fact and fiction in tuberculosis vaccine research: 10 years later. Lancet Infectious Diseases
Zeitschriftenartikel
6 (6), e20568 (2011)
The IFN-gamma-Inducible GTPase, Irga6, Protects Mice against Toxoplasma gondii but Not against Plasmodium berghei and Some Other Intracellular Pathogens. PLoS ONE
Zeitschriftenartikel
6 (6), e20568 (2011)
The IFN-gamma-Inducible GTPase, Irga6, Protects Mice against Toxoplasma gondii but Not against Plasmodium berghei and Some Other Intracellular Pathogens. PLoS ONE
Zeitschriftenartikel
11 (5), S. 2152 - 2156 (2011)
Cells as Factories for Humanized Encapsulation. Nano Letters
Zeitschriftenartikel
41 (4), S. 981 - 991 (2011)
Impact of inducible co-stimulatory molecule (ICOS) on T-cell responses and protection against Mycobacterium tuberculosis infection. European Journal of Immunology